-
1
Adoptive transfer of natural killer cells in therapeutic treatment of COVID-19 patients
Published 2025-02-01“…We discuss potential sources of NK cells for adoptive transfer therapy, critical factors influencing their therapeutic efficacy, and considerations for clinical translation in COVID-19 treatment. …”
Get full text
Article -
2
Clinically relevant orthotopic pancreatic cancer models for adoptive T cell transfer therapy
Published 2024-01-01“…Immunotherapy, including adoptive T cell transfer therapy, has not impacted the outcomes in patients with PDAC, due in part to the hostile tumor microenvironment (TME) which limits T cell trafficking and persistence. …”
Get full text
Article -
3
Prospectives of T-cells genetic programming in adoptive immunotherapy of malignancies
Published 2016-09-01Subjects: Get full text
Article -
4
Safe engineering of CAR T cells for adoptive cell therapy of cancer using long‐term episomal gene transfer
Published 2016-05-01Get full text
Article -
5
Experimental myocardial infarction induces altered regulatory T cell hemostasis, and adoptive transfer attenuates subsequent remodeling.
Published 2014-01-01“…<h4>Background</h4>Ischemic cardiac damage is associated with upregulation of cardiac pro-inflammatory cytokines, as well as invasion of lymphocytes into the heart. Regulatory T cells (Tregs) are known to exert a suppressive effect on several immune cell types. …”
Get full text
Article -
6
-
7
Adoptively transferred macrophages for cancer immunotherapy
Published 2025-05-01“…Here, we demonstrate that adoptively transferred macrophages, with optimal activation prior to administration, act as a potent cellular cancer therapeutic platform against a murine melanoma model.Method The macrophage therapy was prepared from bone marrow-derived macrophages, pretreated ex vivo with an activation cocktail containing interferon-γ, tumor necrosis factor-α, polyinosinic:polycytidylic acid, and anti-CD40 antibody. …”
Get full text
Article -
8
-
9
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells
Published 2024-06-01“…Background How distinct methods of host preconditioning impact the efficacy of adoptively transferred antitumor T helper cells is unknown.Methods CD4+ T cells with a transgenic T-cell receptor that recognize tyrosinase-related peptide (TRP)-1 melanoma antigen were polarized to the T helper 17 (Th17) phenotype and then transferred into melanoma-bearing mice preconditioned with either total body irradiation or chemotherapy.Results We found that preconditioning mice with a non-myeloablative dose of total body irradiation (TBI of 5 Gy) was more effective than using an equivalently dosed non-myeloablative chemotherapy (cyclophosphamide (CTX) of 200 mg/kg) at augmenting therapeutic activity of antitumor TRP-1 Th17 cells. …”
Get full text
Article -
10
ADOPTIVE CELL THERAPY: CURRENT ADVANCES
Published 2020-03-01“…The main part of the article provides information on the mechanisms of adoptive T cell (unmodified and genetically modified) transfer, the creation of dendritic cell vaccines and cytokine-induced killers (CIK). …”
Get full text
Article -
11
Regional and intratumoral adoptive T-cell therapy
Published 2024-12-01“…Building upon the experience of regional administration in other immunotherapies, the regional administration of adoptive cell therapies is being assessed to overcome this challenge, granting a first round of access of the transferred T cells to the tumor niche and thereby ensuring their activation and expansion. …”
Get full text
Article -
12
Adoptive transfer of membrane-restricted IL-12-TCR T cells promotes antigen spreading and elimination of antigen-negative tumor variants
Published 2024-11-01“…Target antigen loss resulting either from non-uniform antigen expression or defects in antigen processing and presentation machinery is one well-characterized resistance mechanism. Constitutively expressed membrane-anchored interleukin-12 (caIL-12) has demonstrated enhanced antitumor activity and low systemic exposure in multiple preclinical adoptive T-cell treatment models with homogeneous tumor antigen expression. …”
Get full text
Article -
13
Platelet-derived microparticles adoptively transfer integrin β3 to promote antitumor effect of tumor-infiltrating T cells
Published 2024-12-01“…Furthermore, T cells and platelet-derived microparticles (PMPs) co-culture assay revealed that PMPs adoptively transferred integrin β3 to T cells and positively regulated T cell immune response. …”
Get full text
Article -
14
-
15
NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial
Published 2024-11-01Subjects: Get full text
Article -
16
An integral membrane constitutively active heparanase enhances the tumor infiltration capability of NK cells
Published 2025-12-01Subjects: “…Adoptive cell transfer…”
Get full text
Article -
17
Clinical factors associated with growth and neoantigen reactivity of tumor infiltrating lymphocytes from metastatic epithelial cancers
Published 2025-06-01Subjects: Get full text
Article -
18
The significance of the omentum in locoregional immunotherapy for peritoneal carcinomatosis
Published 2023-12-01Subjects: “…Adoptive cell transfer…”
Get full text
Article -
19
Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8+ T cells eradicates peritoneal metastases in mouse models
Published 2023-12-01Subjects: Get full text
Article -
20
Regenerative and hepatospecific activity of total RNA from xenogenic bone marrow cells
Published 2021-04-01Subjects: Get full text
Article